The Task Force of the European Academy of Neurology and the Peripheral Nerve Society published updated guidelines in 2024 on the diagnosis and treatment of Guillain-Barré syndrome (GBS), which ...

The singer-songwriter, 49, opened up about his health following his 2023 diagnosis with Guillain-Barré syndrome in an interview with Vulture published on Wednesday, May 14. "I’m okay.

The Move GBS Forward campaign highlights a promising new approach to treatment of the disease. Annexon Biosciences CEO Doug ...

First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005) Compar ...

The Karnataka High Court ruling came in the case of a man diagnosed with Guillain-Barré Syndrome (GBS), who had been in the ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome ...

FDA Meeting for Tanruprubart (formerly ANX005), the First Potential Targeted Therapy for GBS, Scheduled for Second Quarter 2025 Ahead of Planned BLA Submission Open-Label Tanruprubart FORWARD Study ...

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today ...

Dr Kumar has been under intensive care and ventilator support since June 23, 2024. On November 29, 2024, specialists at the Bangalore Medical College and Research Institute’s Neurology Department ...

Sufjan Stevens gave a rare health update following his 2023 diagnosis with Guillain-Barré syndrome "I’m okay. Situation normal, all up, kind of a thing," Stevens said in an interview with Vulture ...